Alkermes reports data from Phase Ib narcolepsy treatment trial

Alkermes reports data from Phase Ib narcolepsy treatment trial

Submitted by admin on April 10, 2024 - 6:00pm
Source: 
Clinical Trials Arena
News Tags: 
Alkermes
clinical trials
narcolepsy
ALKS 2680
Headline: 
Alkermes reports data from Phase Ib narcolepsy treatment trial
snippet: 

Alkermes has shared positive topline data from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a Phase Ib study of ALKS 2680 as a potential once-daily treatment for narcolepsy.

Do Not Allow Advertisers to Use My Personal information